AbbVie announced The Lancet published results from three pivotal Phase 3 clinical trials – U-ACHIEVE (induction), U-ACCOMPLISH and U-ACHIEVE (maintenance) – evaluating upadacitinib (RINVOQ)...
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved both Opdivo (nivolumab) (injection for intravenous use) in combination with...
Juniper Networks, a leader in secure, AI-driven networks, announced that King’s College International School Bangkok (King’s Bangkok), a leading education provider for local and...
Telesign, the leading provider of customer identity and engagement solutions, unveiled a new brand identity reflecting the company’s corporate transformation and redefined business strategy....
